![Michelle Seltenrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 908 $ in data 31/08/2026
Michelle Seltenrich is currently Vice President-Operations at Rakovina Therapeutics, Inc., a position starting in 2026.
Formerly, Ms. Seltenrich was Vice President-Operations at Sirona Biochem Corp.
from 2014 to 2023 and Manager-Business Development at Forbes Medi-Tech, Inc. from 2004 to 2008.
Education includes an undergraduate degree from the University of British Columbia in 1996 and an MBA from Simon Fraser University in 2008.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/09/2026 | 43.438 ( 0,21% ) | 5 908 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
| SIRONA BIOCHEM CORP. | Direttore operativo | 01/08/2023 |
Forbes Medi-Tech, Inc.
 Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Corporate Officer/Principal | 01/05/2008 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Health Technology |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
